Workflow
Forbes
icon
搜索文档
Will Mastercard Stock Gain On Approaching Earnings?
Forbes· 2025-07-22 22:15
Photo by Joan Cros Garcia/Corbis via Getty ImagesCorbis via Getty Images Mastercard (NYSE:MA) is scheduled to announce its second-quarter earnings on Thursday, July 31, 2025. Earnings are anticipated to reach approximately $4.02 per share, representing an increase of nearly 11% compared to the previous year, according to consensus estimates, while revenues are expected to rise by 14% to $7.95 billion. This growth is likely to be fueled by robust cross-border transaction volume and value-added services. Serv ...
What Next For Navitas Stock After 2x Rise This Year?
Forbes· 2025-07-22 22:15
公司股价表现 - Navitas Semiconductor(NVTS)股价在周五交易时段上涨近8% 年初至今股价已翻倍[1] - 股价上涨主要受投资者对Navitas与Nvidia合作信心增强的推动[1] 与Nvidia的合作 - 5月Navitas与Nvidia宣布合作 为Nvidia的800V高压直流(HVDC)架构提供支持 该架构旨在提升数据中心能效和可扩展性[1] - 合作可能使Navitas成为Nvidia新HVDC架构中碳化硅(SiC)和氮化镓(GaN)功率芯片的供应商[1] - 但Navitas仅是Nvidia该项目的多个供应商之一 其在每个服务器系统中的占比和收入潜力仍不确定[2] - Nvidia的新闻稿中还提到了Infineon、MPS、ROHM、STMicroelectronics和Texas Instruments等其他半导体供应商[2] 财务与估值 - 公司市销率高达17倍 远高于标普500的3 1倍[4] - 过去三年平均营收增长53 5% 但最近12个月营收下降16 9% 最近季度同比暴跌39 5%[4] - 过去一年营业亏损1 22亿美元 营业利润率低至-164 2% 远差于多数竞争对手[4] - 资产负债表相对稳健 仅690万美元债务 债务权益比0 5%(标普500为19 4%) 现金资产比20 3%[5] 市场表现与风险 - 公司股票在近期多次市场下跌中表现显著差于标普500指数[5] - 当前估值偏高 基本面疲弱 运营表现和财务状况令人担忧[3]
Miss The April Dip? This Big Dividend Still Sells For 20% Off
Forbes· 2025-07-22 22:05
市场情绪与投资策略 - 当前市场处于历史高位但仍存在投资机会 尤其建议通过折价交易的封闭式基金(CEFs)获取收益 许多CEFs提供8%以上的收益率 [3] - CNN恐惧与贪婪指数在4月跌至历史低点3 但三个月后迅速反弹至贪婪区间 主要股指从低点强劲回升 [4] - 在4月市场抛售期间投资纳斯达克和标普500指数分别可获得25%和19%的总回报 证明恐慌性抛售时买入的潜力 [6] 封闭式基金(CEFs)投资价值 - SRH Total Return Fund(STEW)当前收益率达3.8% 是标普500平均股息率(1.2%)的三倍 持仓包含伯克希尔哈撒韦等价值股 [10] - STEW以19.8%的净资产折价交易 投资者可以低于市场价20%的价格获取其投资组合 [11] - STEW过去五年实现120%的总回报 其价值驱动策略适合长期持有 [12] 历史表现与投资时机 - 研究显示在市场创历史新高时投资 表现优于随机时点投资 历史高点往往成为新的市场底部 [8] - 早期高点如2013年的市场峰值已被超越 错过当时投资机会的投资者将损失后续三倍的收益 [8] - 投资策略应持续买入 在市场下跌时加大投入 这与巴菲特"永不卖股"的理念一致 [9]
Buy Or Sell Apple Stock Ahead Of Q3 Earnings?
Forbes· 2025-07-22 22:05
Photo by Spencer Platt/Getty ImagesGetty ImagesApple (NASDAQ:AAPL) is set to announce its fiscal Q3 2025 earnings on Thursday, July 31. Traditionally, this timeframe tends to be a seasonally weaker quarter for the company, due to the timing right before its major product launches in the fall. Earnings are estimated to be approximately $1.42 per share, according to consensus projections, representing a slight rise compared to the same quarter last year, while revenues are expected to increase by 3.3% year-ov ...
American Airlines Goes Under The Microscope On Thursday
Forbes· 2025-07-22 21:03
A United plane lands as an American plane taxis to takeoff at SFO in March. (Photo by Tayfun Coskun ... More )Anadolu )Anadolu via Getty ImagesToplineAs it reports second quarter earnings on Thursday, American Airlines has to fight the perception that it is doomed to be the permanent bronze metal holder among the three global U.S. carriers.American Is Under The Gun From United CEO Scott KirbyExpectations for American have been diminished by punishing commentary from Scott Kirby, CEO of rival United Air Line ...
Peacock Streaming Service Increasing Subscription Prices This Week
Forbes· 2025-07-22 01:35
TV remote control is seen with Peacock logo displayed on a screen in this illustration photo taken ... More in Krakow, Poland on February 6, 2022. (Photo by Jakub Porzycki/NurPhoto via Getty Images)NurPhoto via Getty ImagesNBC Universal’s Peacock streaming service is boosting the prices of its monthly and yearly streaming packages this week.Peacock launched on April 15, 2020, and primarily contains content from the NBC Universal library, which includes NBC-TV programming and Universal Pictures releases (Wic ...
Why Has GE Vernova Stock Moved 68%?
Forbes· 2025-07-21 21:25
GE Vernova股价表现 - 公司股票自2024年初作为独立能源实体上市以来已飙升近68% 远超市场预期并跑赢标普500指数[1] - 股价波动性虽存在 但Trefis高质量投资组合提供替代选择 该组合自推出以来回报率达91% 持续跑赢标普500[1][4] 业务增长驱动因素 - 受益于能源基础设施超级周期 包括AI数据中心扩张、电气化和电网发展带来的强劲需求[1] - 燃气轮机、电网技术和可再生能源解决方案订单激增 未交付订单总额突破1200亿美元 呈现多年饱和状态[1] - AI能源热潮持续发酵 公司涡轮机产品处于核心地位[3] 公司经营改善 - 从GE分拆后初期被视为工业属性强且增长缓慢 但该认知已被扭转[2] - 资产负债表显著增强 利润率提升 新管理层展现出卓越执行力[2] 未来展望 - 市场高度关注7月23日发布的Q2财报 若继续超预期并展示持续盈利能力 上涨趋势或将延续[3] - AI能源需求未见衰减迹象 公司核心产品将持续受益[3] Trefis投资组合 - 高质量投资组合(HQ Portfolio)包含30只股票 过去四年持续稳定跑赢标普500指数[4] - 该组合通过分散投资实现优于基准指数的回报 同时降低风险波动[4]
What's Happening With PepsiCo Stock?
Forbes· 2025-07-21 21:20
核心观点 - 百事公司Q2财报超预期 股价单日大涨7% 并重申全年业绩指引 同时公布北美业务振兴计划[1] - 相比可口可乐 百事估值更具吸引力 北美业务有望在未来季度改善[2] - 当前股价145美元下 百事仍具投资价值 因其估值低于历史水平且财务健康[2][11] 财务表现 - 近3年收入年均增长4.3% 但过去12个月下降0.3%至920亿美元 最新季度收入同比增1%至227亿美元[6] - 营业利润110亿美元 营业利润率11.5% 经营性现金流110亿美元 利润率12.2% 净利润76亿美元 净利率8.2%[13] - 债务规模510亿美元 市值2000亿美元 债务权益比25.8% 现金及等价物80亿美元 占总资产7.6%[13] 估值比较 - 市盈率26.4倍 略低于标普500的26.9倍 市销率2.0倍 显著低于标普500的3.1倍[6] - 股价/自由现金流25.3倍 高于标普500的20.9倍[6] - 当前市盈率18倍 显著低于过去4年平均22倍的水平[11] 抗风险能力 - 2022年通胀冲击中股价跌幅19.4% 优于标普500的25.4%[14] - 2020年疫情危机中跌幅29.3% 优于标普500的33.9% 并在当年内收复失地[14] - 2008年金融危机中跌幅42.4% 显著优于标普500的56.8% 但耗时5年恢复[14] 业务挑战 - 北美市场面临消费者偏好变化和桂格燕麦召回事件影响[1] - 营业利润率11.5%和净利率8.2%均低于标普500平均水平[13]
Coca Cola Earning Tomorrow, Alphabet And Tesla Earnings Later This Week
Forbes· 2025-07-21 21:20
Tesla is scheduled to announced earnings later this week. Can Elon Musk convince investors he's ... More focused on the business and not politics? (Photo by Apu Gomes/Getty Images)Getty ImagesKey Takeaways Tech leads weekly gains; Nasdaq rises 1.5% on momentum Earnings season heats up; 20% of S&P 500 reporting Tariff deadline nears; investors cautious despite strong sentiment dataWith the exception of the Dow Jones Industrial Average, which was virtually flat, most major averages posted gains for the week. ...
Sarepta Therapeutics: Why Is SRPT Stock Crashing?
Forbes· 2025-07-21 21:00
CANADA - 2025/06/08: In this photo illustration, the Sarepta Therapeutics logo is seen displayed on ... More a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesSarepta Therapeutics has plunged to new lows below $13, down over 35% in recent trading, after rejecting the FDA’s request to voluntarily halt all shipments of Elevidys following a third death tied to the gene therapy. Just days after our previous analyses highlig ...